ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 72 filers reported holding ALLAKOS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $165,000 | -90.8% | 16,859 | -0.1% | 0.00% | -88.9% |
| Q3 2021 | $1,787,000 | +20.7% | 16,883 | -2.6% | 0.01% | +28.6% |
| Q2 2021 | $1,480,000 | -85.8% | 17,341 | -80.9% | 0.01% | -87.5% |
| Q1 2021 | $10,440,000 | -20.5% | 90,957 | -3.0% | 0.06% | -13.8% |
| Q4 2020 | $13,132,000 | +270.1% | 93,803 | +115.3% | 0.06% | +195.5% |
| Q3 2020 | $3,548,000 | +10.3% | 43,564 | -2.7% | 0.02% | -12.0% |
| Q2 2020 | $3,218,000 | -4.5% | 44,781 | -40.9% | 0.02% | -37.5% |
| Q1 2020 | $3,371,000 | -90.0% | 75,759 | -78.6% | 0.04% | -88.6% |
| Q4 2019 | $33,733,000 | +23.8% | 353,743 | +2.1% | 0.35% | +11.8% |
| Q3 2019 | $27,255,000 | +1845.4% | 346,619 | +972.0% | 0.31% | +2135.7% |
| Q2 2019 | $1,401,000 | +6.7% | 32,335 | -0.3% | 0.01% | 0.0% |
| Q1 2019 | $1,313,000 | -26.8% | 32,417 | -5.6% | 0.01% | -44.0% |
| Q4 2018 | $1,794,000 | +16.1% | 34,324 | -0.0% | 0.02% | +56.2% |
| Q3 2018 | $1,545,000 | – | 34,339 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |